Skip to Main Content

Author Details

Eric Vallabh Minikel
2012
37
21
PMIDPaper TitleJournal TitlePublished Year
37188501A single-cell map of antisense oligonucleotide activity in the brain.Nucleic Acids Res2023
36651748Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease.2023
36824749A single-cell map of antisense oligonucleotide activity in the brain.bioRxiv2023
35133987Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS.JCI Insight2022
36271285Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials.Scientific Reports2022
35994510Analysis of non-human primate models for evaluating prion disease therapeutic efficacy.PLoS Pathogens2022
34373650Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans.Nature2021
33536628Author Correction: Evaluating drug targets through human loss-of-function genetic variation.Nature2021
33536625Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans.Nature2021
33173159Implications of new genetic risk factors in prion disease.Nature Reviews Neurology2021
34517052Novel quaternary structures of the human prion protein globular domain.Biochimie2021
32552681Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.BMC Med2020
32199098Towards a treatment for genetic prion disease: trials and biomarkers.Lancet Neurol2020
32098855Autoantibodies against the prion protein in individuals with mutations.Neurology2020
32461654The mutational constraint spectrum quantified from variation in 141,456 humans.Nature2020
32776089Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints.Nucleic Acids Res2020
31145742Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.PLoS Genet2019
31558565Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.Mol Cell Proteomics2019
31861275Characterization of the Prion Protein Binding Properties of Antisense Oligonucleotides.Biomolecules2019
30609406Using High-Resolution Variant Frequencies Empowers Clinical Genome Interpretation and Enables Investigation of Genetic Architecture.Am J Hum Genet2019
31171647Age at onset in genetic prion disease and the design of preventive clinical trials.Neurology2019
31119194Antisense oligonucleotides: A primer.Neurology: Genetics2019
31361599Antisense oligonucleotides extend survival of prion-infected mice.JCI Insight2019
30936307Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.Proc Natl Acad Sci U S A2019
29795570Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.PLoS Genet2018
28229513Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.Hum Mutat2017
28630944ClinVar data parsing.Wellcome Open Res2017
28518168Using high-resolution variant frequencies to empower clinical genome interpretation.Genet Med2017
27532257Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.Genet Med2017
27535533Analysis of protein-coding genetic variation in 60,706 humans.Nature2016
26926995Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion science.Journal of Experimental Medicine2016
26791950Quantifying prion disease penetrance using large population control cohorts.Sci Transl Med2016
27764668Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.Neuron2016
25954003Human genomics. Effect of predicted protein-truncating genetic variants on the human transcriptome.Science2015
24614762Autism spectrum disorder genetics: diverse genes with diverse clinical outcomes.Harvard Review of Psychiatry2014
25279981Ascertainment bias causes false signal of anticipation in genetic prion disease.American Journal of Human Genetics2014
22269506Cyclist safety on bicycle boulevards and parallel arterial routes in Berkeley, California.Accident Analysis and Prevention2012
  • 1 - 37 of 37

Recommended Authors

Collaborators

Broad Institute of MIT and Harvard
Co-authored papers 15
Broad Institute of MIT and Harvard
Co-authored papers 11
Broad Institute of MIT and Harvard
Co-authored papers 9
Massachusetts General Hospital
Co-authored papers 9
Co-authored papers 8
Broad Institute of MIT and Harvard
Co-authored papers 8
Co-authored papers 8
Broad Institute
Co-authored papers 7
Co-authored papers 6
Massachusetts General Hospital
Co-authored papers 6
Broad Institute of MIT and Harvard
Co-authored papers 5
Co-authored papers 5
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 5
Co-authored papers 5
Broad Institute of MIT and Harvard
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
Co-authored papers 4
Regeneron Pharmaceuticals
Co-authored papers 4
Vertex Pharmaceuticals
Co-authored papers 4
Partners Healthcare Center for Personalized Genetic Medicine
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Brigham and Women's Hospital
Co-authored papers 3
Co-authored papers 3
University of Southampton
Co-authored papers 3
Brotman Baty Institute for Precision Medicine, University of Washington
Co-authored papers 3